Tirzepatide is studied as a dual-receptor peptide in controlled research environments where investigators are evaluating the interaction between GIP receptor signaling, GLP-1 receptor activity, insulinotropic pathway behavior, glucose-dependent metabolic regulation, appetite-associated signaling models, adipose tissue metabolism, and energy homeostasis biology.
